TMTakuo Mizukami

Takuo Mizukami

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Takuo Mizukami has a total of 349 co-authors. Here are the top co-authors by number of shared publications:

  • Haruka Momose

    Center for Next-Generation Biologics Research, National Institute of Infectious Diseases, Japan Institute for Health Security, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011, Japan

    34 shared publications
  • Isao Hamaguchi

    Department of Clinical Laboratory, Subaru Health Insurance Society Ota Memorial Hospital, Gunma, Japan

    27 shared publications
  • Kazunari Yamaguchi

    Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan

    17 shared publications
  • Kazuya Takizawa

    Department of Safety Research on Blood and Biological Products, National Institute of Infectious Disease, Tokyo, Japan

    15 shared publications
  • Madoka Kuramitsu

    Center for Next-Generation Biologics Research, National Institute of Infectious Diseases, Japan Institute for Health Security, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011, Japan

    14 shared publications
  • Keiko Furuhata

    Affiliation Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Musashi–Murayama, Tokyo, Japan

    12 shared publications

Latest Publications

  • Open Access

    Molecular Evidence of Human T‑Cell Leukemia Virus Type 1 Transmission by Needlestick Injury in Healthcare Workers

    by Masahito Tokunaga, Madoka Kuramitsu, Masumichi Saito, Miyuki Yoshimori, Jun Odawara, Yoshikiyo Ito, Hitomi Nakamura, Yasuko Sagara, Mieko Ishii, Naomi Nojiri, et al.

    Human T‑cell leukemia virus type 1 (HTLV‑1) is a retrovirus that spreads primarily through cell‐to‐cell transmission. Occupational transmission of HTLV‐1 by needlestick injury is considered exceedingly rare, with no reported molecularly confirmed cases. We report two healthcare workers who experienced accidental needlestick injuries while caring for patients seropositive for HTLV‑1 and subsequently seroconverted. Full‑length HTLV‑1 proviral sequencing revealed complete nucleotide identity between source patients and infected nurses. These strains belonged to the HTLV‐1 subtype 1a Japanese subgroup but were distinct from 315 previously registered strains. Proviral integration site analysis demonstrated nonoverlapping integration profiles between source patients and healthcare workers, providing direct evidence of de novo HTLV‑1 infection rather than expansion of transferred infected cells. Longitudinal analysis in one case showed dynamic clonal turnover between 5 and 14 months after transmission; > 90% of infected‐cell clones were replaced, although the proviral load remained stable and low. Serological profiling revealed transiently elevated immunoglobulin M responses to Gag p19 peptides during early infection, followed by gradual immunoglobulin G maturation. These findings provide the first molecular confirmation of HTLV‑1 transmission via needlestick injury resulting in de novo infection, revealing an under‐recognized occupational exposure route and supporting reconsideration of post‐exposure testing strategies, particularly in endemic regions.

  • Persistence and Local Maintenance of STLV-1 Infection in the Vaginal Epithelium of Postmenopausal Japanese Macaques

    by Yohei Seki, Mami Uemura, Kenta Tezuka, Megumi Murata, Akihisa Kaneko, Maureen Kidiga, Poonam Grover, Sakura Hayashi, Isao Hamaguchi, Hirofumi Akari, et al.

    Background: Human T-cell leukemia virus type 1 (HTLV-1) and simian T-cell leukemia virus type 1 (STLV-1) primarily infect CD4+ T cells and spread via cell-to-cell contact in vivo. However, the mechanism underlying viral establishment and persistence in local tissues remain poorly understood. From the perspective of sexually transmitted infections, this study aimed to visualize the infection status of the genital epithelium in relation to sexual STLV-1 infection before and after menopause. Methods: In this study, we evaluated viral localization in the genital epithelium of naturally infected female Japanese macaques with STLV-1, which is highly homologous to HTLV-1. Results: A marked increase in the proviral load of STLV-1 was observed in both the vaginal epithelium and peripheral blood in post compared with premenopausal individuals. Immunostaining showed the expression of glucose transporter 1 (GLUT1), a receptor for HTLV-1, in the basal layer of the vaginal epithelium. Additionally, in situ hybridization revealed strong expression of the viral accessory factor SBZ, the STLV-1 homolog of HBZ, relative to the pX region, which contains the Tax and Rex genes within the vaginal epithelium, indicating its involvement in latent infections at that site. In postmenopausal macaques, thinning of the vaginal epithelium was observed in association with decreased estradiol levels. Furthermore, more diverse and unique clones were identified in the vaginal epithelium of postmenopausal macaques than in peripheral blood mononuclear cells. Conclusions: These findings highlight the vaginal epithelium may serve as a site for the maintenance of persistent and de novo STLV-1 infections within the genital tract.


  • Development of a novel safety assessment method for quality control of mRNA vaccines based on lung biomarker gene expression

    by Kou Hiraga, Haruka Momose, Wakako Kuribayashi, Mami Uemura, Sayuri Sakuragi, Kiyoko Nojima, Mieko Ishii, Keiko Imai, Jun-Ichi Maeyama, Kazumi Nakano, et al.


  • Identification of Occult Simian T-Cell Leukemia Virus Type 1 Infection in Japanese Macaques

    by Maureen Kidiga, Megumi Murata, Poonam Grover, Hirotaka Ode, Yasumasa Iwatani, Yohei Seki, Madoka Kuramitsu, Mayumi Morimoto, Takayoshi Natsume, Akihisa Kaneko, et al.

    Background: Primate T-cell leukemia virus type 1 (PTLV-1), classified into the genus Deltaretrovirus, persists in infected primates and can lead to adult T-cell leukemia and inflammatory diseases. Unlike hepatitis viruses, it remains unclear whether PTLV-1 could cause occult infection, a rare latent infection status characterized by detectable provirus without accompanying antibody responses. Methods: A longitudinal study was conducted to characterize mother-to-child transmission of simian T-cell leukemia virus type 1 (STLV-1) in Japanese macaques (JMs). Stored blood samples obtained from STLV-1–infected JM mothers and their offspring were analyzed for proviral loads, antiviral antibody titers, proviral DNA sequencing, transcriptional capability, and clonality of the infected cells. Results: One JM infant was found to be positive for proviral DNA without detectable anti-STLV-1 antibodies. The seronegative infection persisted for at least 5 years, despite positive antibody responses to other viruses that are widespread in JMs. Further analyses of the infant's blood demonstrated that (1) the provirus had no defective mutations, (2) tax messenger RNA expression could be induced by in vitro culture, and (3) substantial numbers of heterogeneous clones of STLV-1–infected cells were undergoing sequential turnover. In an additional retrospective study of a large JM cohort, 3 of 38 offspring of STLV-1–infected mothers were found to be persistently infected with STLV-1 without seroconversion. Conclusions: Our findings demonstrate that maternal STLV-1 transmission can occasionally persist for years without seroconversion. This represents the first discovery of occult infection in the genus Deltaretrovirus.


  • Open Access

    Report of the Ninth Asian National Control Laboratory Network meeting in 2024, with a focus on regional harmonization of regulatory systems to prepare for cross-border transfer of plasma

    by Chan Woong Choi, Youngju Choi, Yuyun Siti Maryuningsih, Jin Ho Shin, Piyamaporn Chantarasomchin, Takuo Mizukami, Siaw Wee Ng, Dung Luu Thi, Dio Ramondrana, Geraldine N. Dimapilis, et al.


  • Identification of Natural Remission of Mother-to-Child Retroviral Transmission

    by Poonam Grover, Megumi Murata, Maureen Kidiga, Sakura Hayashi, Hirotaka Ode, Yasumasa Iwatani, Mayumi Morimoto, Takayoshi Natsume, Akihisa Kaneko, Jun-Ichirou Yasunaga, et al.

    Background: Spontaneous remission once a retroviral infection has been established does not occur and infection persists lifelong. Methods: Stored blood samples obtained from simian T-cell leukemia virus type 1 (STLV-1)-infected Japanese macaque (JM; Macaca fuscata) mothers and their offspring during long-term follow-up as well as periodic health checkups were analyzed for proviral DNA levels, anti-STLV-1 antibody titer, DNA sequence, and viral clonality in peripheral blood mononuclear cells. Results: We found spontaneous remission after the establishment of retrovirus mother-to-child transmission (MTCT); 3 JM infants were positive for the provirus at 5 and 8 months of age; however, no evidence of persistent STLV-1 infection was found in any of these infants thereafter up to 3 years of age. The viral env sequencing showed the presence of signature nucleotide polymorphisms, which were identical between each mother and infant but not others, suggesting STLV-1 MTCT. STLV-1–infected cells were capable of viral transmission and were composed of a heterogeneous population of clones, which were completely replaced between 5 and 8 months of age, suggesting the possibility of ongoing de novo infection from mother to infant cells. Furthermore, a retrospective study showed that 8 of 38 infants born to STLV-1–infected mothers developed transient infection comparable to the cases above. Conclusions: Our findings demonstrate for the first time that spontaneous remission can occur after the establishment of retroviral MTCT. Our results unveil the unique dynamics of retroviral infection during MTCT.


  • Open Access

    Report for the Eighth Asian National Control Laboratory Network meeting in 2023: Self-sufficiency strategy of plasma-derived medicinal products and regulatory harmonisation

    by Chan Woong Choi, Youngju Choi, Yuyun Siti Maryuningsih, Bayu Wibisono, Jong Won Kim, Dio Ramondrana, Takuo Mizukami, Masaki Ochiai, Azraini Abdul Samat, Caren Mangorangca, et al.


  • Identification of a Self-Assembling Small-Molecule Cancer Vaccine Adjuvant with an Improved Toxicity Profile

    by Shao-Hua Zhuo, Naotaka Noda, Kou Hioki, Shuyu Jin, Tomoya Hayashi, Kou Hiraga, Haruka Momose, Wen-Hao Li, Lang Zhao, Takuo Mizukami, et al.

    Protein or peptide cancer vaccines usually include immune potentiators, so-called adjuvants. However, it remains challenging to identify structurally simple, chemically accessible synthetic molecules that are effective and safe as vaccine adjuvant. Here, we present cholicamide ss (6), a self-assembling small-molecule vaccine adjuvant with an improved toxicity profile and proven efficacy in vivo. We demonstrate that cholicamide ss (6), which is less cytotoxic than its parent compound, forms virus-like particles to potently activate dendritic cells with the concomitant secretion of cytokines. When combined with a peptide antigen, cholicamide ss (6) potentiated the antigen presentation on dendritic cells to induce antigen-specific T cells. As a therapeutic cancer vaccine adjuvant in mice, a mixture of cholicamide ss (6) and a peptide antigen protected mice from the challenges of malignant cancer cells without overt toxicity. Cholicamide ss (6) may offer a translational opportunity as an unprecedented class of small-molecule cancer vaccine adjuvants.


  • Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the BA.1 and BA.2 Omicron variants

    by Yohei Seki, Yasuo Yoshihara, Kiyoko Nojima, Haruka Momose, Shuetsu Fukushi, Saya Moriyama, Ayumi Wagatsuma, Narumi Numata, Kyohei Sasaki, Tomoyo Kuzuoka, et al.